Anti-Mouse CD120a (TNFR1) [Clone 55R-170]
Anti-Mouse CD120a (TNFR1) [Clone 55R-170]
Product No.: T440
Clone 55R-170 Target Tumor Necrosis Factor Receptor I Formats AvailableView All Product Type Monoclonal Antibody Alternate Names TNFRSF1A, P55, TBP1, CD120a, FPF, MGC19588, TNF-R, TNF-R55, TNFAR, TNFR1, TNFR55, TNFR60, p55-R, p60 Isotype IgG1 Applications ELISA Indirect , IP , N , WB |
Antibody DetailsProduct DetailsReactive Species Mouse Host Species Armenian Hamster Immunogen Recombinant Mouse TNF RI Extracellular Domain Product Concentration ≥ 5.0 mg/ml Endotoxin Level < 1.0 EU/mg as determined by the LAL method Purity >95% by SDS-PAGE and HPLC Formulation This monoclonal antibody is aseptically packaged and formulated in 0.01 M phosphate buffered saline (150 mM NaCl) PBS pH 7.2 - 7.4 with no carrier protein, potassium, calcium or preservatives added. Storage and Handling This antibody can be stored for at least eight (8) weeks at 2-8°C. For long-term storage of this monoclonal antibody, aseptically aliquot into working volumes and store at -20°C to -70°C in a manual defrost freezer. Avoid repeated freeze thaw cycles. No detectable loss of activity was observed after six months. Country of Origin USA Shipping Next Day Ambient RRIDAB_2831940 Each investigator should determine their own optimal working dilution for specific applications. See directions on lot specific datasheets, as information may periodically change. DescriptionDescriptionSpecificity Clone 55R-170 recognizes mouse CD120a. Background CD120 can refer to two members of the tumor necrosis factor receptor superfamily- CD120a (TNFR1) or CD120b (TNFR2). CD120a is a 55kD Type I transmembrane protein receptor that binds both TNF-α and TNF-β (LT-α). In association with TRADD and RIP, the receptor crosslinking induced by TNF-α or TNF-β trimers is vital for signal transduction, leading to apoptosis, NF-B activation, increased expression of proinflammatory genes, tumor necrosis, and cell differentiation depending on cell type and differentiation state. CD120b is a 75 kD type I transmembrane protein that binds both TNF-α and TNF-β. In conjunction with TRAF1 and TRAF2, the receptor crosslinking induced by TNF-α or TNF-β trimers is critical for signal transduction that may lead to apoptosis, NF-kB activation, increased expression of proinflammatory genes, tumor necrosis, and cell differentiation depending on cell type and differentiation state. TNF-α is a 17.5 kD protein that mediates inflammation and immunity caused by the invasion of viruses, bacteria, and parasites by initiating a cascade of cytokines that increase vascular permeability, thus bringing macrophages and neutrophils to the site of infection. TNF-α secreted by the macrophage causes the blood to clot which provides containment of the infection. TNF-α binding to surface receptors brings about various biologic activities that include cytolysis and cytostasis of many tumor cell lines In vitro, hemorraghic necrosis of tumors In vivo, increased fibroblast proliferation, and enhanced chemotaxis and phagocytosis in neutrophils. TNF-β (LT-α) is a 25 kD protein that has a significant impact on the maintenance of the immune system including the development of secondary lymphoid organs. TNF-β has dual functions. It may function to prevent growth of cancer cells or it may facilitate the development of tumors. TNF-β is involved in the regulation of cell survival, proliferation, differentiation, and apoptosis and, if unregulated, can result in a constantly active signaling pathway, resulting in uncontrolled cellular growth and creation of tumors. Additionally, TNF-β is involved in innate immune regulation and has been shown to prevent tumor growth and obliterate cancerous cell lines. Antigen Distribution CD120a is constitutively expressed in most tissues. Research Area Immunology . Innate Immunity Leinco Antibody AdvisorPowered by AI: AI is experimental and still learning how to provide the best assistance. It may occasionally generate incorrect or incomplete responses. Please do not rely solely on its recommendations when making purchasing decisions or designing experiments. Use of Clone 55R-170 in In Vivo Mouse StudiesClone 55R-170 is a well-characterized monoclonal antibody that specifically targets mouse CD120a, also known as Tumor Necrosis Factor Receptor I (TNFR1 or TNFRSF1A). It is an Armenian hamster IgG1 antibody that has been explicitly developed and purified for in vivo use in mice. Primary Functions
Administration and Formulation
Key Applications in Research
Selectivity and Specificity
Summary Table
ConclusionClone 55R-170 is a critical tool in mouse immunology research for selectively blocking TNFR1 signaling in vivo. Its use has elucidated the distinct roles of TNF receptors in inflammation, infection, and cytokine storm, providing mechanistic insights and therapeutic hypotheses relevant to human disease. Researchers should use low-endotoxin, carrier-free preparations and follow established in vivo protocols to maximize experimental validity. The correct storage temperatures for the sterile packaged Armenian Hamster monoclonal antibody to Mouse CD120a (Clone 55R-170) are as follows:
It is important to maintain sterile conditions and avoid freeze-thaw cycles to preserve the antibody's efficacy. Commonly Used Antibodies and Proteins Paired with 55R-17055R-170 is a monoclonal antibody that specifically targets the mouse TNF Receptor I (CD120a/p55/TNFRSF1A). It has been widely used in research applications, and in the literature, several other antibodies and proteins are commonly paired with or referenced alongside 55R-170, particularly for multi-step assays or functional characterization. Commonly Paired Antibodies
Other Commonly Referenced Proteins
Functional and Technical Context
Summary Table: Key Pairings
ConclusionIn the literature, 55R-170 is most commonly used alongside 55R-286 in ELISA formats, 55R-176 and anti-p75 antibodies in functional and comparative studies, and biotinylated detection systems (SAv-PE, anti-Armenian hamster IgG) in flow cytometry. The natural ligands TNF-? and LT-?, as well as downstream signaling adaptors like TRADD and RIP, are also frequently referenced in the context of TNFRI biology when 55R-170 is employed to block or modulate receptor activity. Key Findings from Clone 55R-170 Citations in Scientific LiteratureClone 55R-170 is a monoclonal antibody that specifically recognizes mouse CD120a, also known as Tumor Necrosis Factor Receptor Type I (TNFR1). While the direct, primary scientific literature specifically reporting novel biological findings using clone 55R-170 is limited in the provided search results, there are several important insights based on its documented specificity, functional applications, and the biology of its target, TNFR1. Specificity and Functional Use of Clone 55R-170
Biological Significance of TNFR1 (CD120a)While most cited literature does not describe novel findings specifically from experiments using clone 55R-170, the broader scientific understanding of TNFR1s rolewhich 55R-170 interrogatesincludes:
Summary Table: Key Points
Limitations in the LiteratureThere is limited direct evidence in the provided search results of novel biological discoveries attributed specifically to experiments using clone 55R-170. Most references focus on its validation as a specific TNFR1-blocking tool rather than reporting new mechanistic insights generated by its use. The broader literature on TNFR1, however, underscores its critical role in inflammation, apoptosis, and immune regulation, all of which are pathways that would be disrupted by 55R-170-mediated blockade. ConclusionClone 55R-170 is a well-characterized, functional-grade monoclonal antibody against mouse TNFR1, widely used to block TNFR1 signaling and study its role in inflammation, apoptosis, and immune responses. While direct, novel scientific findings from the use of this clone are not extensively detailed in the provided literature, its application is foundational for elucidating the specific contributions of TNFR1 in diverse biological contexts. For deeper mechanistic insights, additional primary literature specifically employing 55R-170 in experimental models would be required. References & Citations1. Dana, R. et al. (2000) Arch Ophthalmol. 118: 1666 2. Donner, DB. et al. (2008) J Immunol. 181: 1288 3. Pasparakis, M. et al. (2008) Nat Immunol. 9: 1015 Technical ProtocolsCertificate of Analysis |
Formats Available
Prod No. | Description |
---|---|
T583 | |
T249 | |
T575 | |
T576 | |
T577 | |
T579 | |
T581 | |
T248 | |
T250 | |
T950 | |
T440 |
